New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know
14/04/2026-22:57 14/04/2026-23:01 מחשבים וטכנולוגיה Forbes Innovation דיווח
A new pancreatic cancer drug called daraxonrasib cut the risk of death by 60% in a Phase 3 trial. What it is, how it works, side effects and when it c
